Skip to content

Mechanism of Bifidobacterium Combined with Lactobacillus Rhamnosus in Improving Infantile Eczema

Mechanism of Bifidobacterium Combined with Lactobacillus Rhamnosus in Improving Infantile Eczema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069680
Enrollment
Unknown
Registered
2023-03-23
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile eczema

Interventions

Group 1:2 intervention once daily
Group 2:2 placebo once daily

Sponsors

Shaoguan Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 2 Years

Inclusion criteria

Inclusion criteria: 1) Infants > 36 weeks of gestational age, 6 months to 3 years of age, male or female: 2) Infant formula fed exclusively at the first six months of age and without prebiotics and probiotics at the last six months; 3) Birth weight > 2500g and = 25 as determined by Hanifin and Rajka criteria.

Exclusion criteria

Exclusion criteria: 1) Patients with diseases that seriously affect the digestion and absorption of test samples; 2) Patients who have used systemic corticosteroids within 1 month, antihistamines within 7 days or local calcineurin inhibitors within 1 month; 3) Patients who are using drugs that may affect the test effect (such as hormones, anti-tumor drugs, sedatives or other muscle relaxants, etc.); 4) Seborrheic dermatitis, contact dermatitis and other skin diseases; 5) Patients with diarrhea, fever, congenital diseases or hereditary diseases; 6) autoimmune diseases, chronic diseases, failure to thrive and other endocrine system-related diseases; 7) Infant formula containing beneficial antibiotics or probiotics that interfere with the results of the study; 8) Infants diagnosed with rhinitis and asthma by medical institutions; 9) Those who did not sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
SCORing Atopic Dermatitis;

Secondary

MeasureTime frame
Infant Dermatitis Quality of Life Questionnaire;Children's Quality of Life Index Questionnaire;Dermatitis Family Impact Questionnaire;Incidence rate of eczema after intervention in infants;Recurrence frequency of eczema;Frequency of eczema recurrence;Duration of eczema;The content of immunological markers in serum;Infant growth indicators;Intestinal microflora structure;Incidence rate of rhinitis;Incidence rate of asthma;Infant defecation;Infant sleep status;Infant crying;Infant breastfeeding;

Countries

China

Contacts

Public ContactYan Chen,Wei Wu

Shaoguan Maternity and Child Health Care Hospital

Ahua615@sina.com18666618822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026